Difficulty: Medium
Average Score: 64%
Practice
A patient is receiving dabigatran, 150 mg twice daily, for atrial fibrillation. Which condition would be a concern if the patient were to receive this dose?
Correct answer
C
Rationale
Dabigatran, a direct thrombin inhibitor, is renally excreted renal impairment risks accumulation and bleeding, requiring dose adjustment (e.g., 75 mg). Asthma , liver enzymes , and MI history don't directly affect dosing. Nurses monitor creatinine clearance, as in Option C, critical for safe anticoagulation in atrial fibrillation.